Press release
ATTR Amyloidosis Treatment Market: Growth Fueled by Advances in Therapies and Rising Patient Awareness | Akcea Therapeutics, Inc., Prothena Corporation plc
ATTR Amyloidosis Treatment Market
The ATTR amyloidosis treatment market is estimated to be valued at USD 3.8 Bn in 2024 and is expected to reach USD 6.82 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The ATTR Amyloidosis Treatment market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the ATTR Amyloidosis Treatment market, including market size, trends, drivers and constraints, competitive aspects, and prospects for future growth.
Request a Sample Copy with More Details: - https://www.coherentmi.com/industry-reports/attr-amyloidosis-treatment-market/request-sample
Scope of the ATTR Amyloidosis Treatment Market:
The ATTR Amyloidosis Treatment market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Major Players Operating in the ATTR Amyloidosis Treatment Market:
• Alnylam Pharmaceuticals
• Ionis Pharmaceuticals
• Eidos Therapeutics
• Akcea Therapeutics
• Prothena Corporation plc
• Corino Therapeutics
• AstraZeneca plc
ATTR Amyloidosis Treatment Market Segments:
❖ By Type
• Hereditary ATTR Amyloidosis
• Familial Amyloid Polyneuropathy (FAP)
• Familial Amyloid Cardiomyopathy (FAC)
• Wild-type ATTR Amyloidosis
• Senile Systemic Amyloidosis
• Isolated Atrial Amyloidosis
❖ By Treatment
• Pharmacological Therapies
• Transthyretin Stabilizers (e.g., Tafamidis)
• RNA Interference Therapies (e.g., Patisiran)
• Antisense Oligonucleotides (e.g., Inotersen)
• Organ Transplantation
• Liver Transplantation
• Heart Transplantation
• Supportive Care
• Symptomatic Treatments
• Rehabilitation Services
❖ By Route of Administration
• Oral
• Intravenous
• Subcutaneous
❖ By End User
• Hospitals
• Specialty Clinics
• Homecare Settings
Geographical Landscape:
The ATTR Amyloidosis Treatment Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities.
➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)
This report offers actionable growth insights and an extensive study comprising secondary research, primary interviews with industry stakeholders, and competitors, validation, and triangulation with the CoherentMI regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights.
Trends and Opportunities:
The ATTR Amyloidosis Treatment market has seen several trends in recent years, and understanding these trends is crucial to stay ahead of the competition. The increasing demand for ATTR Amyloidosis Treatment in various industries presents several growth opportunities for players in the market.
Would you like to have an opportunity to explore more explore more details, If yes, access our full report @ https://www.coherentmi.com/industry-reports/attr-amyloidosis-treatment-market
Key Benefits for Stakeholders:
⏩ The study includes a comprehensive analysis of current ATTR Amyloidosis Treatment Market trends, estimations, and market size dynamics from 2024 to 2031 in order to identify the most potential prospects.
⏩ The five forces study by Porter underlines the role of buyers and suppliers in aiding stakeholders in making profitable business decisions and expanding their supplier-buyer network.
⏩ In-depth research, as well as market size and segmentation, can assist you in identifying current ATTR Amyloidosis Treatment Market opportunities.
⏩ The largest countries in each area are mapped based on their market revenue contribution.
⏩ The ATTR Amyloidosis Treatment Market research report provides an in-depth analysis of the top competitors in the market.
Global ATTR Amyloidosis Treatment Market 2024 Key Insights:
▶ Research and analyze the ATTR Amyloidosis Treatment Market standing and future forecast associated with production, Market price structure, consumption, and historical knowledge.
▶ The report understands the structure of ATTR Amyloidosis Treatment Market trade by distinctive its varied segments and sub-segments.
▶ Market report split the breakdown knowledge by company, products, end-user, and prime countries, with market history knowledge from 2017 to 2024 and forecast to 2031.
▶ Analysis of ATTR Amyloidosis Treatment Market regarding individual growth trends, future prospects, and their contribution to the overall market.
▶ Global ATTR Amyloidosis Treatment Market 2024 report analyzes competitive expansions like agreements, new product launches, and acquisitions.
▶ This research report targets the global key players to characterize sales volume, market revenue, growth potential, drivers, SWOT analysis, and development plans in coming years.
Get access to the latest Edition of this Market Study (comprising 150 + pages ) @ https://www.coherentmi.com/industry-reports/attr-amyloidosis-treatment-market/buynow
Reasons to buy:
👉 Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
👉 Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
👉 Classify potential new clients or partners in the target demographic.
👉 Develop tactical initiatives by understanding the focus areas of leading companies.
👉 Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.
👉 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
👉 Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
More Trending Reports by CoherentMI Market:
Drug Infusion System Market https://www.coherentmi.com/industry-reports/drug-infusion-system-market
Clinically Isolated Syndrome (CIS) Market https://www.coherentmi.com/industry-reports/clinically-isolated-syndrome-cis-market
Diverticulitis Market https://www.coherentmi.com/industry-reports/diverticulitis-market
Emphysema Market https://www.coherentmi.com/industry-reports/emphysema-market
☎ Contact Us:
Mr. Shah
CoherentMI,
U.S.: +1-650-918-5898
U.K: +44-020-8133-4027
Australia: +61-2-4786-0457
INDIA: +91-848-285-0837
Email: sales@coherentmi.com
Website: https://www.coherentmi.com
About CoherentMI:
At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today's rapidly changing business landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ATTR Amyloidosis Treatment Market: Growth Fueled by Advances in Therapies and Rising Patient Awareness | Akcea Therapeutics, Inc., Prothena Corporation plc here
News-ID: 3706787 • Views: …
More Releases from CoherentMI
How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 …
The latest report on the "Autosomal Dominant Polycystic Kidney Disease Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores…
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts …
The latest report on the "Ocular Hypertension Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical factors such…
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportun …
The most recent in-depth analysis from CoherentMI offers a comprehensive global perspective on the evolving Epithelioid Sarcoma Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides clarity on both micro…
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and …
The latest report on the "Clear Cell Ovarian Cancer Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical…
More Releases for Amyloid
Islet Amyloid Polypeptide Market Analysis Current Landscape and Future Outlook
The global Islet Amyloid Polypeptide market is projected to reach approximately USD 255.8 million by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2033.
Islet Amyloid Polypeptide Market Overview
The Islet Amyloid Polypeptide market is gaining traction due to its critical role in metabolic disorders, particularly in type 2 diabetes research and treatment. Islet Amyloid Polypeptide (IAPP), also known as amylin, is closely associated with insulin…
Cerebral Amyloid Angiopathy Pipeline Landscape: 10+ Emerging Therapies Targeting …
Cerebral Amyloid Angiopathy (CAA) is a progressive cerebral small vessel disease marked by amyloid-β (Aβ) protein deposition in the walls of leptomeningeal and cortical blood vessels. Often occurring in the elderly and closely linked with Alzheimer's disease, CAA contributes significantly to cognitive impairment, spontaneous intracerebral hemorrhage, and cerebral microbleeds. Despite its high clinical burden, there are currently no approved disease-modifying therapies specifically for CAA, and diagnosis remains challenging without advanced…
Amyloid Peptides Market to Witness Astonishing Growth by 2029
Amyloid Peptides Market is anticipated to grow at a significant CAGR during the forecast period. Growing favourable investment, as well as reimbursement facilities in the developed economic countries, is one of the major factors that is expected to fuel the global amyloid peptides market during the forecast period. Moreover, a growing number of clinical trials and research activities to develop treatment and drugs for Alzheimer's are also anticipated to boost…
Amyloid Peptides Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Amyloid Peptides Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Amyloid Peptides players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Amyloid Peptides with respect to individual growth…
Islet Amyloid Polypeptide: Therapeutic Developments to Witness Growth
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP) or Amylin is a peptide hormone. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. It inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. The molecules developed by companies in Phase II, Phase I and Preclinical stages…
Islet Amyloid Polypeptide: Therapeutic Developments to Witness Growth
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP) or Amylin is a peptide hormone. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. It inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. The molecules developed by companies in Phase II, Phase I and Preclinical stages…
